Article Sidebar

PDF
Date Published: 12/07/2023
Online Published: 17/07/2023
Abstract Views: 246
Views PDF: 209
DOI: https://doi.org/10.58490/ctump.2023i61.525
Issue
No. 61 (2023): HỘI NGHỊ THƯỜNG NIÊN HỌC VIÊN – SINH VIÊN NGHIÊN CỨU KHOA HỌC NĂM 2023
Section
Article
How to Cite
Huynh, L. T. T., Pham, T. P., Tran, D. H., & Ngo, H. T. (2023). PROGNOSIS VALUE OF CARDIOVASCULAR EVENTS OF BLOOD ACID URIC CONCENTRATION IN PATIENTS WITH CHRONIC HEART FAILURE. Cantho Journal of Medicine and Pharmacy, 61, 240-245. https://doi.org/10.58490/ctump.2023i61.525

PROGNOSIS VALUE OF CARDIOVASCULAR EVENTS OF BLOOD ACID URIC CONCENTRATION IN PATIENTS WITH CHRONIC HEART FAILURE

Le Trong Tuong Huynh1, Thanh Phong Pham1, Dieu Hien Tran1, Hoang Toan Ngo2,
1 Can Tho Central General Hospital
2 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

  Background: Uric acid is one of the predictors of cardiovascular events in patients with cardiovascular disease, including heart failure. Objectives: To determine the average concentration and predictive value of cardiovascular events of blood uric acid in patients with heart failure. Material and methods: A cross-sectional descriptive study on 198 chronic heart failure patients treated at the Department of Cardiology, Can Tho Central General Hospital, from January 2020 to December 2021. Results: The average concentration of blood uric acid in heart failure patients was 572±3.85µmol/L. There were 130 patients with hyperuricemia, accounting for 65%. Age, serum uric acid level, and NT-proBNP level had a predictive value of cardiovascular events in patients with heart failure. The uric acid cut-off points of 512 µmol/L had a predictive value for cardiovascular events in patients with heart failure. Conclusion: Hyperuricemia was an independent risk factor for cardiovascular events in patients with heart failure.

Article Details

Keywords

Blood uric acid, cardiovascular events, heart failure

References

1. Donald Lloyd-Jones, Robert J. Adams, Todd M. Brown. Heart disease and stroke statistics— 2010 update: a report from the American Heart Association. Circulation. 2010. 121, e46-e215, http://doi.org/ 10.1161/CIRCULATIONAHA.109.192667.
2. Nadja Scherbakov, Maximiliane Bauer, Anja Sandek. Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail. 2015. 17(10), 1015-1021, http://doi.org/10.1002/ejhf.317.
3. M. Y. Nadkar, V I Jain. Serum uric acid in acute myocardial infarction. J Assoc Physicians India. 2018. 56, 759-762.
4. Piotr Ponikowski, Bauersachs, J. Soltani. Guidelines of the ESC 2021 on heart failure. European Heart Journal. 2021. 1, 12-18, https://doi.org/10.1093/eurheartj/ehab368.
5. Leonardo Tamariz, Arash Harzand, Ana Palacio. Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis. Congest Heart Fail. 2011. 17(1), 25-30, http://doi.org/ 10.1111/j.1751-7133.2011.00200.x.
6. Trần Kim Sơn. Nghiên cứu kháng insulin ở bệnh nhân suy tim mạn. Luận án Tiến sỹ Y học. Trường Đại học Y Dược. Đại học Huế. 2017.
7. Barbara Sposato, Franco Romeo, Joshua M Hare. Uric acid lowering therapy in cardiovascular diseases. Int J Cardiol. 2015. 213(3), 20-202, https://doi.org/10.1016/j.ijcard.2015.08.088.
8. Yang Y, Qin X, Li Y. Relationship between Serum Uric Acid and Mortality Risk in Hemodialysis Patients: A Multicenter Prospective Cohort Study. Am J Nephrol. 2020. 51(10), 823-832, http://doi.org/ 0.1159/000509258.
9. Hyoung-Seob Park , Hyungseop Kim, Ji-Hyun Sohn. Combination of uric acid and NT-ProBNP: a more useful prognostic marker for short-term clinical outcomes in patients with acute heart failure. Korean J Intern Med. 2010. 25(3), 253-259, http://doi.org/ https://doi.org/10.3904/kjim.2010.25.3.253.
10. Israel Gotsman, Andre Keren, Chaim Lotan, Donna R Zwas. Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival. J Card Fail. 2012. 18(9), 694-701, http://doi.org/ https://doi.org/10.1016/j.cardfail.2012.06.528.
11. Sanae Hamaguchi, Tomoo Furumoto, Miyuki Tsuchihashi-Makaya. Hyperuricemia predicts adverse outcomes in patients with heart failure. Int J Cardiol. 2010. 151(2), 143-147, http://doi.org/ https://doi.org/10.1016/j.ijcard.2010.05.002.